SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-144950"
 

Search: onr:"swepub:oai:DiVA.org:umu-144950" > Anti-Rift Valley fe...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound

Islam, Md. Koushikul (author)
Umeå universitet,Infektionssjukdomar,Umea Univ, Dept Clin Microbiol, Infect Dis, Umea, Sweden.
Strand, Mårten (author)
Umeå universitet,Virologi,Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden.
Saleeb, Michael (author)
Umeå universitet,Kemiska institutionen,Umea Univ, Dept Chem, Umea, Sweden.
show more...
Svensson, Richard (author)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Institutionen för farmaci,UDOPP
Baranczewski, Pawel (author)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Institutionen för farmaci,UDOPP
Artursson, Per (author)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Institutionen för farmaci,UDOPP
Wadell, Göran (author)
Umeå universitet,Virologi,Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden.
Ahlm, Clas (author)
Umeå universitet,Infektionssjukdomar,Umea Univ, Dept Clin Microbiol, Infect Dis, Umea, Sweden.
Elofsson, Mikael (author)
Umeå universitet,Kemiska institutionen,Umea Univ, Dept Chem, Umea, Sweden.
Evander, Magnus (author)
Umeå universitet,Virologi,Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden.
show less...
 (creator_code:org_t)
2018-01-31
2018
English.
In: Scientific Reports. - : NATURE PUBLISHING GROUP. - 2045-2322. ; 8
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Rift Valley fever virus (RVFV) is a mosquito-borne hemorrhagic fever virus affecting both humans and animals with severe morbidity and mortality and is classified as a potential bioterror agent due to the possible aerosol transmission. At present there is no human vaccine or antiviral therapy available. Thus, there is a great need to develop new antivirals for treatment of RVFV infections. Benzavir-2 was previously identified as potent inhibitor of human adenovirus, herpes simplex virus type 1, and type 2. Here we assess the anti-RVFV activity of benzavir-2 together with four structural analogs and determine pre-clinical pharmacokinetic parameters of benzavir-2. In vitro, benzavir-2 efficiently inhibited RVFV infection, viral RNA production and production of progeny viruses. In vitro, benzavir-2 displayed satisfactory solubility, good permeability and metabolic stability. In mice, benzavir-2 displayed oral bioavailability with adequate maximum serum concentration. Oral administration of benzavir-2 formulated in peanut butter pellets gave high systemic exposure without any observed toxicity in mice. To summarize, our data demonstrated potent anti-RVFV activity of benzavir-2 in vitro together with a promising pre-clinical pharmacokinetic profile. This data support further exploration of the antiviral activity of benzavir-2 in in vivo efficacy models that may lead to further drug development for human use.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Microbiology in the medical area (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view